Loading...
XASX
WNX
Market cap3mUSD
Oct 09, Last price  
0.08AUD
1D
0.00%
1Q
36.36%
IPO
-99.27%
Name

Wellnex Life Ltd

Chart & performance

D1W1MN
XASX:WNX chart
P/E
—
P/S
0.22
EPS
—
Div yield, %
—
Shrs. gr., 5y
39.28%
Rev. gr., 5y
83.46%
Revenues
25m
+5.13%
455,0131,5069,9789,978928,4261,441,000887,000934,0001,195,00018,607,00027,892,00016,932,00023,625,00024,838,000
Net income
-5m
L-70.85%
-158,140-316,291-535,587-535,586-4,151,000-19,833,000-9,911,000-46,266,000-24,688,000-7,449,000-13,846,000-13,739,000-15,604,000-4,549,000
CFO
-3m
L+321.92%
202,642-127,910-640,635-3,706,000-6,059,000-12,674,000-7,570,000-4,376,000-8,611,000-6,189,000-6,818,000-666,000-2,810,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.

Key people

Peter Biantes
Interim Independent Non-Executive Chairman of the Board · since 2020
Tony McKenna
Group Chief Executive Officer, Managing Director · since 2020
Martin Glenister
Co-Founder, Director of Sales
George Karafotias
Chief Financial Officer · since 2019
Mark McCammon
Vice President Global Sales
Angela Coppola
Finance and Administration Executive
Yifang Wang Yvette
Client Engagement Specialist
Li Zheng
Company Secretary, Non-Executive Independent Director · since 2019
IPO date
Mar 15, 2017
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑10
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT